DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Capillary Technologies India Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·28 Sept 2026, 1:41 pm

Capillary Techno India L

Capillary Technologies India Limited has announced the schedule for its upcoming analyst and institutional investor meet. This event is a key opportunity for the company to engage directly with the investment community, providing insights into its business strategy and financial outlook.

For investors, such meetings are crucial as they offer a platform to clarify doubts and understand the management's vision. The information shared can help retail investors assess the company's growth potential and future performance.

Investors should watch for updates on the company's product roadmap, expansion plans, and financial targets discussed during the meet. This will provide a clearer picture of Capillary's trajectory in the competitive tech landscape.